Oxime Impurity of Escitalopram Oxalate
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

227954-88-3Oxime Impurity of Escitalopram Oxalate

● Auf Lager

Katalog-Nr.::VE0021567
CAS-Nr.::227954-88-3
Summenformel::C20H23FN2O2
Molare Masse::342.41 g/mol

Zusätzliche Informationen zu CAS 227954-88-3

Parent drug

Escitalopram

IUPAC-Name

1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carbaldehyde Oxime

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

SMILES

FC1=CC=C(C2(CCCN(C)C)OCC3=C2C=CC(/C=N/O)=C3)C=C1

InChI

InChI=1S/C20H23FN2O2/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22-24)12-16(19)14-25-20/h4-9, 12-13, 24H, 3, 10-11, 14H2, 1-2H3/b22-13+

Beschreibung

The compound Oxime Impurity of Escitalopram Oxalate is a highly characterized reference material that meets stringent regulatory standards | including those set by USP | EMA | JP | and BP. This product is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Escitalopram production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally | the product comes with a detailed Structure Elucidation Report (SER) | ensuring its precision and reliability for comprehensive analytical use.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url